We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
  • Events
No Result
View All Result
Africanian
  • News
  • News 24/7
  • Politics
  • Business
  • Health
  • Sports
  • Travel
  • World
    • US
    • Russia
    • Europe
    • Asia
    • America
  • Events
No Result
View All Result
Africanian
No Result
View All Result
Home News

Uganda to Start Covid-19 Vaccine Trials in December

The Uganda Virus Research Institute (UVRI) is partnering with Imperial College London to start the first Covid-19 vaccine trial in the country by December.

africanian
August 11, 2020
in News
1 0
0
Uganda to Start Covid-19 Vaccine Trials in December
Share on FacebookShare on TwitterShare via Whatsapp

Prof Pontiano Kaleebu, the UVRI Director, told Daily Monitor yesterday that they are completing necessary internal processes before beginning to enrol volunteers for the trial.

“We are working on a protocol to start a clinical trial for a vaccine that is being developed in the United Kingdom by Imperial College London. The trial will begin by around December. The trial is going to focus on the safety of the vaccine and its immunogenicity,” he said.

Immunogenicity is the ability of a foreign substance to provoke an immune response in the body of a human.

There has been an uproar in the African continent on using Africans as guinea pigs to test foreign vaccines.

Related Post

The Central African Republic, is investing in green infrastructure to protect 300,000 residents

The Central African Republic, is investing in green infrastructure to protect 300,000 residents

July 24, 2025
Kenya: AfriLabs and Konza Technopolis Sign Strategic Deal to Boost Innovation Across Africa

Kenya: AfriLabs and Konza Technopolis Sign Strategic Deal to Boost Innovation Across Africa

July 23, 2025

Liberia unleashes youth capital to dream big

July 22, 2025

The Youth Charter: Mandela’s legacy transformed through sport

July 21, 2025

Prof Kaleebu, however, advised Ugandans to think positively about the vaccine.

The expert said the clinical trial is in the best interest of ensuring that the vaccines developed are effective and safe for the nationals.

“Even the antibiotics and the polio vaccines we are using here in the country were developed by foreign people,” Prof Kaleebu added.

The clinical trial for the Imperial College vaccine is being done in more than 200 people in the UK’s areas of Chelsea and Westminster Hospital NHS Foundation Trust, Imperial College Healthcare NHS Trust, among others.

Prof Kaleebu, however, said he is confident that people will participate in the clinical trial process.

“We shall educate people. Even for Ebola [vaccine], we never failed to get volunteers. Sometimes those who are opposed are the noisiest; you may think they are carrying the opinion of the whole world,” he added.

Although several vaccines are based on weakened or modified forms of the coronavirus, the Imperial vaccine uses synthetic strands of genetic code, called RNA (Ribonucleic acid) which mimics the coronavirus.

The earlier report from the college for the completed preclinical trial, shows that the vaccine produced highly specific antibodies against Covid-19 in mice, which were able to neutralise the virus.

The vaccine, when injected in the muscle causes the self-amplification of the RNA, generating numerous copies of itself.

The numerous RNA produced will then train the body immune system to quickly recognise and fight coronavirus. The RNA does this by instructing the body cells to make copies of a spike protein found on the outside of the coronavirus, according to information from the developers.

The experts also say that because only a tiny amount of genetic code is used, one litre of its synthetic material can be enough to produce two million doses.

Vaccine devt

Dr Monica Musenero, the senior presidential adviser on epidemics, who is also coordinating the vaccine development process among country’s scientists, said there is progress.

Dr Musenero had earlier told this newspaper that four vaccine candidates are lined up for development by Makerere University, Kampala International University, UVRI and other medical research Institutes in the country.

“We are not giving many details for a strategic reason. We are doing our best here. We know Covid-19 started in their countries early and so they are ahead of us; we shall also reach there,” she said.

Source: allafrica.com
Tags: breaking newsCovid-19 Vaccine TrialsUganda
africanian

africanian

Related Posts

The Central African Republic, is investing in green infrastructure to protect 300,000 residents
Environment

The Central African Republic, is investing in green infrastructure to protect 300,000 residents

by Africanian
July 24, 2025
Kenya: AfriLabs and Konza Technopolis Sign Strategic Deal to Boost Innovation Across Africa
News

Kenya: AfriLabs and Konza Technopolis Sign Strategic Deal to Boost Innovation Across Africa

by africanian
July 23, 2025
Liberia unleashes youth capital to dream big
Business

Liberia unleashes youth capital to dream big

by Africanian
July 22, 2025
No Result
View All Result

Africanian News

Is a dedicated project aimed at amplifying the voices of the African Ecosystem and Diaspora. We actively collaborate with initiatives to improve access to education and digital inclusion, both in traditional schools and through digital platforms, for African children.

It’s crucial to emphasize that none of the articles or images featured on our platform are intended for copyright infringement, neither now nor in the future. If you believe that any information, text, image, etc., may be subject to copyright and should be removed, please notify us by sending an email to info@africanian.com

Your dreams matter; your stories matter.

Feel free to explore collaboration opportunities with us. Share your articles, thoughts, interviews, experiments, or no-comment videos by reaching out to info@africanian.com. You can also subscribe to our mailing list to receive the latest updates from Africanian News.

News letter

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Log In

Sign In

Forgot password?

Don't have an account? Register

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.

No Result
View All Result
  • News
  • Politics
  • Business
  • Health
  • Sports
  • Entertainment
  • Tech
  • Travel
  • World

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.